Skip to content

Comparison the use of dyrogesterone and steroid in IVF Cycles.

A comparative study of the use of dydrogesterone and GnRH antagonists in InVitro Fertilization (IVF) cycles.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181031041519N2
Enrollment
200
Registered
2019-06-10
Start date
2019-06-05
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility. Female infertility

Interventions

Intervention 1: Intervention group: Group A (study group): On the second day of the menstrual cycle, all patients undergo vaginal sonography, and in the absence of follicles greater than 10 mm, the tr

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Infertile patients candidates for IVF AMH greater than 1 ng / ml First or second IVF cycle The presence of both ovaries Age less than 40 years

Exclusion criteria

Exclusion criteria: Smoking Presence of uterine anomalies Adrenal insufficiency or uncontrolled thyroid Endometriosis grade 3 or More Couples chromosomal disorder Underlying disorder that can lead to ovulatory dysfunction Repeated failure of IVF

Design outcomes

Primary

MeasureTime frame
Number of mature oocyte. Timepoint: Two weeks after treatment. Method of measurement: Vaginal sonography.

Secondary

MeasureTime frame
LH surge. Timepoint: Two weeks after treatment. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyede Masoumeh Ghazi Mirsaeed

Tehran University of Medical Sciences

dr_ghazi82@yahoo.com+98 21 6693 9320

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026